News Reports

PR NewsWire | Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer’s Disease
Date:2019-11-04

The PR NewsWire.png

ShareTo:
Previous Page:
Economics Times | China okays sale of first home-grown Alzheimer’s drug
Next Page:
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease